跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 506 条关于
“CD320”
全部
506
临床试验
347
药物
141
机构
0
资讯
18
去年
BioAffinity Technologies Secures Patent for Dual-Target Cancer Therapy Using siRNA Against CD320 and LRP2 Receptors
去年
CD20 Bispecific Antibodies Show Promise in Lymphoma Treatment at ASH
去年
Shark-Derived VNARs Show Promise in Targeting CD20 for Lymphoma Therapy
去年
Zamto-cel Shows Promise in Relapsed/Refractory DLBCL with Tandem CD20/CD19 Targeting
去年
Rituxan Approved in Japan for Pediatric Chronic ITP
去年
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
去年
Phase 4 Trial Explores Ozanimod Switch for Stable MS Patients on Anti-CD20 Therapy
去年
Novel CAR-T Cell Therapy Shows 100% Response Rate in Refractory CD30+ Lymphoma Patients
3年前
Bispecific CD20/CD19 CAR T-Cell Therapy Shows Promising Results in Mantle Cell Lymphoma
5年前
Bispecific CAR-T Therapy Targeting CD19/CD20 Shows Promise in Relapsed B-Cell Lymphoma
第 1 页,共 2 页
上一页
下一页